Avanir, a leading global medical technology contract research organization (CRO) and consulting services partner, has announced the acquisition of Anagram , headquartered in Barcelona, ​​Spain, one of the leading medtech CROs in the Iberian Peninsula providing medtech solutions to the Spanish, pan-European and beyond markets.

Founded in 1998, Anagram offers its clients a full-service CRO model, including diagnostic imaging core laboratory services (quality control and central review of images for pivotal clinical trials), primarily focusing on the therapeutic areas of cardiology, oncology and neurology, with research operations in the US, UK, Spain, Netherlands, France, Germany, etc.

Anagram is an ideal partner for Avanir, enabling the expansion of our CRO operations in Spain while broadening our access to the growing MedTech market. The addition will provide us with added scale to support cross-selling opportunities and eliminate dependency on our current outsourcing partners. Avanir's clients will benefit from an expanded geographic footprint and an enhanced list of experts with specialized expertise in key therapeutic areas.

"This partnership with Anagram furthers our vision to be a trusted global partner in the MedTech industry, driving innovation from research to bedside and improving patient outcomes around the world. It gives us a significant footprint in Spain and Southern Europe and expands our oncology capabilities while further strengthening our cardiovascular and neurology businesses," said Jason Monteleone , President and CEO of Avanir.

About Avanir

Avanir is a leading global medtech clinical research organization and consulting partner specializing in medical devices, diagnostics/IVD, and digital health. Core services include full-service clinical research outsourcing, market entry, cost reimbursement, regulatory, and product development consulting services. Avanir's vision is to be your trusted global partner supporting the evolution of medical technology, from innovation to commercialization to improving patient health and well-being. Move medical technology forward, you need Avanir.

About Anagrams

Anagram is a Clinical Research Organization (CRO) based in Spain that offers high quality services in the clinical development and post-marketing testing of medicines and medical devices. Services include centralized evaluation (core lab) of images by skilled experts, analysis and reporting. Anagram has extensive expertise in cardiology, neurology and oncology.

The official version of this press release is the original language version. The translated language versions are provided for the convenience of readers and have no legal effect. When using the translated version as a reference, please refer to the original language version, which is the only version that has legal effect.

Contact

Holli Kroeker
+1 308 338 2358
pr@scorrmarketing.com

Jasmine Saba
+1 214 418 3201
jasmine.saba@avaniaclinical.com
 

 

Source: businesswire.com

Report Abuse